2024-04-01 03682012 2025-03-31 03682012 2024-04-01 2025-03-31 03682012 2024-03-31 03682012 2023-04-01 2024-03-31 03682012 uk-core:WithinOneYear 2024-03-31 03682012 uk-core:WithinOneYear 2025-03-31 03682012 uk-core:AfterOneYear 2024-03-31 03682012 uk-core:AfterOneYear 2025-03-31 03682012 uk-core:ShareCapital 2025-03-31 03682012 uk-core:ShareCapital 2024-03-31 03682012 uk-core:RetainedEarningsAccumulatedLosses 2025-03-31 03682012 uk-core:RetainedEarningsAccumulatedLosses 2024-03-31 03682012 uk-bus:Director1 2024-04-01 2025-03-31 03682012 uk-core:ToolsEquipment 2024-04-01 2025-03-31 03682012 uk-core:FurnitureFittings 2024-04-01 2025-03-31 03682012 uk-core:ToolsEquipment 2024-03-31 03682012 uk-core:FurnitureFittings 2024-03-31 03682012 uk-core:FurnitureFittings 2025-03-31 03682012 uk-core:ToolsEquipment 2025-03-31 03682012 uk-core:WithinOneYear 2025-03-31 03682012 uk-core:WithinOneYear 2024-03-31 03682012 uk-core:AfterOneYear uk-core:Secured 2025-03-31 03682012 uk-core:AfterOneYear uk-core:Secured 2024-03-31 iso4217:GBP xbrli:pure 03682012 uk-bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 03682012 uk-bus:FRS102 2024-04-01 2025-03-31 03682012 uk-bus:FilletedAccounts 2024-04-01 2025-03-31 03682012 uk-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31
Baytree Labs Ltd
Registered Number:03682012
For the year ended 31 March 2025
England and Wales
Unaudited Financial Statements
2
For the year ended 31 March 2025
Baytree Labs Ltd
Contents Page
1
Statement of Financial Position
2 to 4
Notes to the Financial Statements
3
Registered Number :
03682012
As at 31 March 2025
Baytree Labs Ltd
Statement of Financial Position
£
£
2024
2025
Notes
Fixed assets
Property, plant and equipment
18,296
20,961
2
18,296
20,961
Current assets
Trade and other receivables
356,015
414,617
3
84,081
Cash and cash equivalents
813
415,430
440,096
Trade and other payables: amounts falling due within one year
(146,953)
(173,744)
4
293,143
241,686
Net current assets
Total assets less current liabilities
259,982
314,104
Trade and other payables: amounts falling due after more than one
year
(313,807)
(258,780)
5
1,202
Net assets
297
Capital and reserves
Called up share capital
200
200
Retained earnings
1,002
97
1,202
297
Shareholders' funds
For the year ended 31 March 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each
financial year and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and
which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable
to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Mitul Thobhani Director
These financial statements were approved and authorised for issue by the Board on 30 December 2025 and were signed by:
The notes form part of these financial statements
1 of 4
4
For the year ended 31 March 2025
Baytree Labs Ltd
Notes to the Financial Statements
Statutory Information
Baytree Labs Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 03682012.
Principal place of business:
Devonshire House
582 Honeypot Lane
Stanmore
Middlesex
HA7 1JS
Registered address:
Unit 21 Kingspark Business Centre
152-178 Kingston Road
New Malden
Surrey
KT3 3ST
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial Reporting Standard
102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The
financial statements have been prepared under the historical costs convention.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax or other similar sales taxes.
Property, plant and equipment
Tangible fixed assets, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
33.33% Reducing balance
Computer equipt and web-site
20% Reducing balance
Furniture,fixtures & equipment
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.
Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate at the date of transaction. Exchange rate differences are taken into account in arriving at the operating result.
Hire purchase and leasing commitments
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
2 of 4
5
For the year ended 31 March 2025
Baytree Labs Ltd
Notes to the Financial Statements Continued
2. Property, plant and equipment
Total
Computer
equipt and
web-site
Furniture,fixtur
es & equipment
£
£
£
Cost or valuation
At 01 April 2024
109,911
80,035
29,876
3,794
3,794
-
Additions
At 31 March 2025
29,876
83,829
113,705
Provision for depreciation and impairment
At 01 April 2024
88,950
68,058
20,892
Charge for year
6,459
4,667
1,792
At 31 March 2025
95,409
72,725
22,684
At 31 March 2025
Net book value
7,192
11,104
18,296
At 31 March 2024
8,984
11,977
20,961
3. Trade and other receivables
2024
2025
£
£
Trade debtors
170,001
45,277
Other debtors
244,616
310,738
356,015
414,617
The debtors above include the following amounts falling due after more than one year:
Other debtors
29,147
29,147
4. Trade and other payables: amounts falling due within one year
2024
2025
£
£
Bank loans and overdraft
9,905
9,945
Trade creditors
1,047
7,590
Taxation and social security
62,349
68,829
Other creditors
100,443
60,589
173,744
146,953
3 of 4
6
For the year ended 31 March 2025
Baytree Labs Ltd
Notes to the Financial Statements Continued
5. Trade and other payables: amounts falling due after more than one year
2024
2025
£
£
Bank loans and overdraft
1,772
11,730
Other creditors
257,008
302,077
258,780
313,807
6. Related party transactions
Mr Mitul Thobhani is a director of Baytree Media Group Limited and has a material shareholding in that company.
During the year, the company made management consultancy charge of £3,000 (2024 : £22,000 to Baytree Media Group
Limited.
The company is controlled by its director, Mr Mitul Thobhani, by virtue of his 100% holding of the voting rights of the shares in
the company.
7. Average number of persons employed
During the year the average number of employees was 6 (2024 : 8)
4 of 4